This is further exemplified in breast cancer mouse models: while overexpression of AKT1 accelerates ErbB-2 mediated mammary tumorigenesis and suppresses tumor invasion [91], overexpression of AKT2 markedly increases the incidence of pulmonary metastases in breast cancer [92]. This evidence concerns the gene AKT2 and breast carcinoma.